Dow AgroSciences and TeselaGen Advance Biodesign Technologies for Agriculture
Collaboration announcement to produce biological design automation platform for accelerating agricultural discovery work.
Using the power of nature in conjunction with advanced technology and informatics to produce and develop solutions for farmers is essential to advance agriculture. Today, TeselaGen Biotechnology Inc., and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced they have entered into a collaboration to produce a state-of-the-art biological design automation platform that can speed discovery work.
“TeselaGen has created a powerful suite of tools for DNA design,” said Daniel R. Kittle, Ph.D., Vice President, Research and Development, Dow AgroSciences. “These tools have the potential to accelerate our discovery efforts focused on providing sustainable solutions to help feed the growing world.”
With a secure computational environment to design and create molecular biology research information, the private-cloud platform will enable scientists at Dow AgroSciences to advance their research to find new crop protection and seed products at an accelerated pace.
Dr. Michael Fero, Chief Executive Officer, TeselaGen, said, “TeselaGen is a platform that automates and optimizes protocol generation for biomanufacturing. This collaboration is a great complement to our previous work in medical and industrial biotechnology. We are very excited to now bring our platform to bear on problems facing farmers.”